Companies: 10,795·Total market cap: $144.5T
Celularity Inc.

Celularity Inc.

CELUNASDAQHealthcare● Active
$0.81
$-0.06(-6.92%)
Market Cap$19528914
P/E Ratio
52W High$4.35
52W Low$0.71

Celularity Inc.(CELU)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CELU · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$26.55M$54.22M$22.77M$17.98M$21.34M
Cost of Revenue$6.36M$14.99M$16.02M$19.66M$9.65M
Gross Profit$20.19M$39.23M$6.75M($1.69M)$11.68M
Gross Margin %(computed)76.04%72.36%29.66%-9.40%54.76%
Operating Expenses
R&D Expenses$15.03M$17.39M$30.46M$78.36M$88.35M
G&A Expenses$0.00M$58.62M$50.53M$65.86M$0.00M
Total Operating Expenses$81.50M$77.59M$199.04M$23.91M$120.74M
Operating Income($61.31M)($38.36M)($192.29M)($25.60M)($109.06M)
Operating Margin %(computed)-230.92%-70.75%-844.44%-142.42%-511.17%
Interest Income$0.26M$0.33M$0.32M$0.36M$0.33M
Interest Expense$6.75M$6.26M$3.02M$0.00M$3.17M
Income Before Tax($91.71M)($57.89M)($196.28M)$14.21M($100.10M)
Income Tax Expense$0.00M$0.00M$0.01M$0.01M$0.02M
Net Income($91.80M)($57.89M)($196.29M)$14.19M($100.12M)
Net Margin %(computed)-345.76%-106.77%-862.04%78.95%-469.27%
Per Share & EBITDA
EPS (Basic)$-3.59$-2.64$-11.02$1.01$-7.87
Wtd Avg Shares25.60M21.89M17.81M13.99M12.73M
EBITDA($77.66M)($43.71M)($183.95M)($138.83M)($88.11M)
EBITDA Margin %(computed)-292.52%-80.61%-807.81%-772.36%-412.98%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Celularity Inc.

关于Celularity Inc.(CELU)损益表

Celularity Inc.(CELU)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CELU实现营收$0.03B,毛利润$0.02B(毛利率76.04%),净利润($0.09B)(净利率-345.76%)。

常见问题

CELU · 4 问

Celularity Inc.(CELU)2025财年营收为$0.03B,同比down51.0%。

CELU revenueCELU salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09